Under-representation of WHO Africa region in HBV clinical trials: The field advances, but in which direction?

The WHO Africa region bears a disproportionate burden of morbidity and mortality related to chronic Hepatitis B Virus (HBV), accounting for an estimated 70% of new infections worldwide. We investigated the extent to which HBV clinical trials (CT) represent populations in this region. Through analysi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lancet Gastroenterol Hepatol
Main Authors: Delphin, Marion, Mohammed, Khadija Said, Downs, Louise O, Lumley, Sheila F, Waddilove, Elizabeth, Okanda, Dorcas, Aliyan, Nadia, Van Schalkwyk, Marije, Anderson, Motswedi, Ocama, Ponsiano, Maponga, Tongai, Torimiro, Judith, Iwuji, Collins, Ndung’u, Thumbi, Matthews, Philippa C, Taljaard, Jantjie
Format: Artigo
Jezik:Inglês
Izdano: 2024
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616036/
https://ncbi.nlm.nih.gov/pubmed/38367632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(23)00315-1
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki